Status:
COMPLETED
Efficacy and Safety of Zolpidem-MR Administered Over a Long Term Period as Needed for Insomnia (ZOLONG)
Lead Sponsor:
Sanofi
Conditions:
Sleep Initiation and Maintenance Disorders
Eligibility:
All Genders
18-64 years
Phase:
PHASE3
Brief Summary
The primary objective of the study is to evaluate the hypnotic efficacy of zolpidem-MR 12.5 mg in comparison with placebo, when administered over a long-term period, on an "as needed" basis, in patien...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- patients with chronic primary insomnia
- The investigator will evaluate whether there are other reasons why a patient may not participate.
Exclusion
Key Trial Info
Start Date :
August 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2006
Estimated Enrollment :
1025 Patients enrolled
Trial Details
Trial ID
NCT00425243
Start Date
August 1 2004
End Date
January 1 2006
Last Update
April 6 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sanofi-Aventis
Malvern, Pennsylvania, United States, 19355